Medication info

Lansoprazole 20 mg (Lansoprazole Sodium) Tablets

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›20mg / 1 tablet
Manufacturer / importer
IQUR Co., Ltd.
Appearance
Yellow round enteric-coated tablet
Packaging
28 tablets (14 tablets/PTP packaging x 2), 28 tablets (14 tablets/AluAlu packaging x 2)
Approval status
Active

MFDS item code 201506843 · Approved 2015.09.30 · Insurance code 674400570

Summary

Main use
Treatment of gastroesophageal reflux disease, peptic ulcers and Helicobacter pylori eradication, and Zollinger-Ellison syndrome
Who takes it
Adults · Children
Adult dose
Gastric and duodenal ulcers: The usual adult dose is rabeprazole sodium 10 mg orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. The usual treatment duration is up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI, proton pump inhibitor), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, 20 mg twice daily is limited to patients with confirmed severe mucosal injury. Symptom relief of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is needed. After symptoms resolve, subsequent symptoms may be controlled using on-demand therapy with 10 mg once daily as needed. Long-term maintenance therapy for gastroesophageal reflux disease: Administer 10 mg or 20 mg orally daily, depending on the patient. Helicobacter pylori eradication: Patients infected with Helicobacter pylori should receive eradication therapy. It is recommended to administer this drug 20 mg with clarithromycin 500 mg and amoxicillin 1 g twice daily for 7 days. Zollinger-Ellison syndrome: The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg daily according to the needs of each patient. Doses up to 100 mg may be administered once daily, while the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this drug for up to 1 year. Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. Use with caution because hepatic function is often reduced.
Child dose
Safety in children has not been established.

Ingredients

Manufacturer
IQUR Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, peptic ulcers and Helicobacter pylori eradication, and Zollinger-Ellison syndrome

  • Gastric ulcer
  • duodenal ulcer
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • symptoms of gastroesophageal reflux disease
  • gastrointestinal ulcers
  • Zollinger-Ellison syndrome
View approved original text

This medication is used to treat ulcers in the digestive system, such as gastric ulcers and duodenal ulcers. It also relieves symptoms of erosive or ulcerative gastroesophageal reflux disease and is effective for long-term maintenance therapy for gastroesophageal reflux disease. Additionally, it may be used in combination with antibiotics to treat gastrointestinal ulcers in patients infected with Helicobacter pylori. It is also applied to rare conditions such as Zollinger-Ellison syndrome to help alleviate symptoms. This medication is widely used for the treatment and symptom relief of stomach and esophageal-related diseases.

How to take

Adult dose

Gastric and duodenal ulcers: The usual adult dose is rabeprazole sodium 10 mg orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. The usual treatment duration is up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI, proton pump inhibitor), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, 20 mg twice daily is limited to patients with confirmed severe mucosal injury. Symptom relief of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is needed. After symptoms resolve, subsequent symptoms may be controlled using on-demand therapy with 10 mg once daily as needed. Long-term maintenance therapy for gastroesophageal reflux disease: Administer 10 mg or 20 mg orally daily, depending on the patient. Helicobacter pylori eradication: Patients infected with Helicobacter pylori should receive eradication therapy. It is recommended to administer this drug 20 mg with clarithromycin 500 mg and amoxicillin 1 g twice daily for 7 days. Zollinger-Ellison syndrome: The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg daily according to the needs of each patient. Doses up to 100 mg may be administered once daily, while the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this drug for up to 1 year. Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. Use with caution because hepatic function is often reduced.

Child dose

Safety in children has not been established.

Precautions

This medication should not be used by individuals with allergies to specific components or those with a history of hypersensitivity to benzimidazole derivatives. Caution is especially necessary in cases of allergy to penicillin or macrolide antibiotics, particularly during combination therapy for Helicobacter pylori eradication. Additionally, patients taking certain heart medications, pregnant or breastfeeding women should not take this medication. Patients with impaired liver function, the elderly, and those with a history of drug allergies should use this medication carefully. This medication contains the dye Yellow No. 4, which can cause allergic reactions in sensitive individuals. If symptoms of an allergic reaction such as skin rash or itching occur, discontinue use immediately, and it is advisable to undergo regular blood tests and liver function tests. Various side effects can manifest in different organs, including the heart, digestive system, nervous system, respiratory system, and skin, so consult a healthcare professional if any abnormal symptoms occur. This medication may increase the risk of bone fractures with long-term use; therefore, caution should be exercised for prolonged use. Furthermore, hypomagnesemia may occur, and magnesium levels should be regularly checked and supplementation may be necessary. Since this medication suppresses gastric acid secretion, there may be a slight increase in the risk of certain bacterial infections; consult a physician if diarrhea symptoms persist. Caution is needed as drowsiness may occur when driving or operating machinery. There may be interactions when used with certain anticancer or antiviral medications; therefore, it is crucial to inform healthcare providers about all medications being taken. It is safest not to use this medication during pregnancy or breastfeeding. In the elderly, the risk of side effects may be heightened due to decreased liver function, so caution is advised upon occurrence of symptoms. Safety in pediatric patients has not been established; therefore, use is not recommended. There is no specific antidote for overdose; appropriate treatment should be administered based on symptoms. This medication should be swallowed whole and not chewed or crushed, and kept out of reach of children. If symptoms of autoimmune diseases such as systemic lupus erythematosus appear during medication use, consult a physician immediately. This medication may affect the results of certain diagnostic tests due to gastric acid suppression, so it is important to notify healthcare professionals before undergoing tests. Serious side effects such as acute kidney inflammation can occur; if fatigue, loss of appetite, or rashes occur, stop taking the medication immediately and consult a healthcare professional. Regular check-ups and strict adherence to medical instructions are essential when this medication is administered long-term.

Side effects

Rash, hives, itching, decrease in red blood cells, decrease in white blood cells, increase in white blood cells, increase in eosinophils, increase in neutrophils, decrease in lymphocytes, anemia, purpura, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, elevated ALT, elevated AST, elevated ALP, elevated γ-GTP, elevated LDH, elevated total bilirubin, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, abnormal electrocardiogram, migraine, syncope, angina, heart block, palpitations, bradycardia, tachycardia, pulmonary embolism, ventricular tachycardia, thrombophlebitis, vasodilation, prolonged QTc, ventricular fibrillation, diarrhea, constipation, abdominal pain, abdominal bloating, dyspepsia, belching, nausea, rectal bleeding, bloody stools, anorexia, cholelithiasis, oral ulcer, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stools, colitis, esophagitis, glossitis, pancreatitis, proctitis, thirst, vomiting, lower abdominal pain, stomach cancer, gastritis, stomatitis, taste disorders, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, sialadenitis, thirst, headache, insomnia, anxiety, dizziness, seizures, abnormal dreams, decreased libido, neuropathy, sensory disturbances, tremors, weakness, hyperesthesia, drowsiness, vertigo, depression, agitation, amnesia, confusion, extrapyramidal syndrome, increased blood volume, decreased muscle power in limbs, sensory neuropathy, decreased grip strength, language confusion, staggering, confusion, spatial disorientation, hypersomnia, cough, pharyngitis, rhinitis, dyspnea, asthma, epistaxis, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, sleep apnea, respiratory depression, interstitial pneumonia, myalgia, lumbago, arthritis, leg cramps, bone pain, arthrosis, bursitis, hypertonicity, neuralgia, single contraction, sweating, alopecia, skin dryness, shingles, psoriasis, skin color changes, toxic epidermal necrolysis, mucous membrane syndrome, erythema multiforme, cataracts, amblyopia, glaucoma, dry eyes, abnormal vision, tinnitus, otitis media, corneal opacification, blurriness, double vision, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, frequency of urination, dysmenorrhea, dysuria, kidney stones, uterine bleeding, polyuria, gynecomastia, elevated total cholesterol, elevated triglycerides, increased BUN, elevated serum thyroid-stimulating hormone, chest pain, chills, fever, urinary tract infection, lethargy, weight gain, visual disturbances, loss of appetite, neck stiffness, phototoxic reactions, hangover effect, weight loss, gout, anaphylaxis, shock, hepatitis, jaundice, hepatic encephalopathy, sudden death, coma, hyperammonemia, rhabdomyolysis, delirium, angioedema, hypomagnesemia, thrombocytopenia, neutropenia, agranulocytosis, hemolytic anemia, pancytopenia, vesicular skin rash, urticarial skin rash, systemic allergic reactions, arthralgia, epileptic nephritis, gynecomastia, increased thyroid-stimulating hormone, erythema multiforme, toxic epidermal necrolysis, mucous membrane syndrome, increased INR, prolonged prothrombin time, bone fractures, Clostridium difficile-associated diarrhea, systemic lupus erythematosus, discoid lupus

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container, protected from air and moisture. It is advisable to maintain room temperature between 1 degree and 30 degrees.

Appearance and packaging

Appearance

Yellow round enteric-coated tablet

Package unit

28 tablets (14 tablets/PTP packaging x 2), 28 tablets (14 tablets/AluAlu packaging x 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.